80 related articles for article (PubMed ID: 20600885)
1. Colonic delivery of carboxyfluorescein by pH-sensitive microspheres in experimental colitis.
Kietzmann D; Moulari B; Béduneau A; Pellequer Y; Lamprecht A
Eur J Pharm Biopharm; 2010 Oct; 76(2):290-5. PubMed ID: 20600885
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal distribution and absorption behavior of Eudragit-coated chitosan-prednisolone conjugate microspheres in rats with TNBS-induced colitis.
Oosegi T; Onishi H; Machida Y
Int J Pharm; 2008 Feb; 348(1-2):80-8. PubMed ID: 17714892
[TBL] [Abstract][Full Text] [Related]
3. Enhanced therapeutic effect of LK-423 in treating experimentally induced colitis in rats when administered in colon delivery microcapsules.
Smrdel P; Cerne M; Bogataj M; Urleb U; Mrhar A
J Microencapsul; 2010; 27(7):572-82. PubMed ID: 20690794
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and toxicity of Eudragit-coated chitosan-succinyl-prednisolone conjugate microspheres using rats with 2,4,6-trinitrobenzenesulfonic acid-induced colitis.
Onishi H; Oosegi T; Machida Y
Int J Pharm; 2008 Jun; 358(1-2):296-302. PubMed ID: 18394832
[TBL] [Abstract][Full Text] [Related]
5. pH-sensitive microsphere delivery increases oral bioavailability of calcitonin.
Lamprecht A; Yamamoto H; Takeuchi H; Kawashima Y
J Control Release; 2004 Jul; 98(1):1-9. PubMed ID: 15245884
[TBL] [Abstract][Full Text] [Related]
6. An oral drug delivery system targeting immune-regulating cells ameliorates mucosal injury in trinitrobenzene sulfonic acid-induced colitis.
Nakase H; Okazaki K; Tabata Y; Uose S; Ohana M; Uchida K; Nishi T; Debreceni A; Itoh T; Kawanami C; Iwano M; Ikada Y; Chiba T
J Pharmacol Exp Ther; 2001 Jun; 297(3):1122-8. PubMed ID: 11356937
[TBL] [Abstract][Full Text] [Related]
7. A pH-sensitive microsphere system for the colon delivery of tacrolimus containing nanoparticles.
Lamprecht A; Yamamoto H; Takeuchi H; Kawashima Y
J Control Release; 2005 May; 104(2):337-46. PubMed ID: 15907584
[TBL] [Abstract][Full Text] [Related]
8. Epithelial heparin delivery via microspheres mitigates experimental colitis in mice.
Pellequer Y; Meissner Y; Ubrich N; Lamprecht A
J Pharmacol Exp Ther; 2007 May; 321(2):726-33. PubMed ID: 17322027
[TBL] [Abstract][Full Text] [Related]
9. Bioefficacy of budesonide loaded crosslinked polyelectrolyte microparticles in rat model of induced colitis.
Crcarevska MS; Dodov MG; Petrusevska G; Gjorgoski I; Goracinova K
J Drug Target; 2009 Dec; 17(10):788-802. PubMed ID: 19938950
[TBL] [Abstract][Full Text] [Related]
10. Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease.
Lamprecht A; Ubrich N; Yamamoto H; Schäfer U; Takeuchi H; Maincent P; Kawashima Y; Lehr CM
J Pharmacol Exp Ther; 2001 Nov; 299(2):775-81. PubMed ID: 11602694
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticles in inflammatory bowel disease: particle targeting versus pH-sensitive delivery.
Meissner Y; Pellequer Y; Lamprecht A
Int J Pharm; 2006 Jun; 316(1-2):138-43. PubMed ID: 16675176
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticles enhance therapeutic efficiency by selectively increased local drug dose in experimental colitis in rats.
Lamprecht A; Yamamoto H; Takeuchi H; Kawashima Y
J Pharmacol Exp Ther; 2005 Oct; 315(1):196-202. PubMed ID: 15980057
[TBL] [Abstract][Full Text] [Related]
13. Colon-Targeted Therapy of Tacrolimus (FK506) in the Treatment of Experimentally Induced Colitis.
Ali AS; Altayari AA; Khan LM; Alharthi SE; Ahmed OA; El-Shitany NA; Ali SS; Saadah OI
Pharmacology; 2020; 105(9-10):541-549. PubMed ID: 31940656
[TBL] [Abstract][Full Text] [Related]
14. Design of pH-sensitive microspheres for the colonic delivery of the immunosuppressive drug tacrolimus.
Lamprecht A; Yamamoto H; Takeuchi H; Kawashima Y
Eur J Pharm Biopharm; 2004 Jul; 58(1):37-43. PubMed ID: 15207535
[TBL] [Abstract][Full Text] [Related]
15. Colon-targeted delivery of budesonide using dual pH- and time-dependent polymeric nanoparticles for colitis therapy.
Naeem M; Choi M; Cao J; Lee Y; Ikram M; Yoon S; Lee J; Moon HR; Kim MS; Jung Y; Yoo JW
Drug Des Devel Ther; 2015; 9():3789-99. PubMed ID: 26229440
[TBL] [Abstract][Full Text] [Related]
16. Con-A conjugated mucoadhesive microspheres for the colonic delivery of diloxanide furoate.
Anande NM; Jain SK; Jain NK
Int J Pharm; 2008 Jul; 359(1-2):182-9. PubMed ID: 18486369
[TBL] [Abstract][Full Text] [Related]
17. Novel formulation of solid lipid microparticles of curcumin for anti-angiogenic and anti-inflammatory activity for optimization of therapy of inflammatory bowel disease.
Yadav VR; Suresh S; Devi K; Yadav S
J Pharm Pharmacol; 2009 Mar; 61(3):311-21. PubMed ID: 19222903
[TBL] [Abstract][Full Text] [Related]
18. Bioadhesive pellets increase local 5-aminosalicylic acid concentration in experimental colitis.
Bautzová T; Rabišková M; Béduneau A; Pellequer Y; Lamprecht A
Eur J Pharm Biopharm; 2012 Jun; 81(2):379-85. PubMed ID: 22386911
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of colon specific drug delivery system bearing 5-ASA and Camylofine dihydrochloride for the treatment of ulcerative colitis.
Dubey R; Dubey R; Omrey P; Vyas SP; Jain SK
J Drug Target; 2010 Sep; 18(8):589-601. PubMed ID: 20088681
[TBL] [Abstract][Full Text] [Related]
20. [Studies on the influence of Candida fungal colonization on the healing process of inflammatory lesions in the colon in rat animal model].
Zwolińska-Wcisło M; Brzozowski T; Budak A; Sliwowski Z; Drozdowicz D; Kwiecień S; Trojanowska D; Rudnicka-Sosin L; Mach T; Konturek SJ; Pawlik WW; Targosz A
Przegl Lek; 2007; 64(3):124-9. PubMed ID: 17941462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
